NEW YORK (GenomeWeb News) - Fluxion Biosciences said today that it has signed an exclusive agreement with Westburg under which the Leusden, Netherlands-based firm will market its BioFlux live cell image analysis platform in Belgium, the Netherlands, Luxembourg, Denmark, Finland, Iceland, Norway, and Sweden.
San Francisco-based Fluxion’s BioFlux 200 system is a microfluidic-based platform designed for live cell imaging in applications such as cell adhesion and microbial biofilm studies.
"The relationship will complement Westburg's product portfolio and give us access to their cell biology customers," said Mark Atlas, director of sales for Fluxion.